Post-Operative Nausea And Vomiting Study In Female Patients

• Status: Completed
• Trial end date: 2005-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Casopitant; Neurokinin-1 Receptor Antagonists

Criteria

Inclusion Criteria:

• Known, specified risk factors for PONV (post operative nausea and vomiting)

• Undergoing gynecologic or gallbladder surgery.

Exclusion Criteria:

• pregnant or breastfeeding

• post-menopausal